Zhongtai Asset Management Plan No. 45 Single Asset Management Plan, managed by Zhongtai Securities (Shanghai) Asset Management Co.,Ltd. signed a share transfer agreement to acquire a 5% stake in Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE : 300158) from Shanxi Zhendong Health Industry Group Co., Ltd. for approximately CNY 340 million on June 17, 2022. Zhongtai Asset Management will pay CNY 6.63 cash per share for 51,374,735 shares of Shanxi Zhendong Pharmaceutical Co. As a part of consideration, the first installment will be paid within 5 working days and the remaining of CNY 272.491594 million will be paid after 18 months. The transaction needs to be reviewed and confirmed by the Shenzhen Stock Exchange before it can go through the relevant procedures for the transfer of shares by agreement at the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited.

Zhongtai Asset Management Plan No. 45 Single Asset Management Plan, managed by Zhongtai Securities (Shanghai) Asset Management Co.,Ltd. completed the acquisition of a 5% stake in Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE : 300158) from Shanxi Zhendong Health Industry Group Co., Ltd. on July 15, 2022.